InvestorsHub Logo
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Thursday, 04/20/2017 7:17:27 AM

Thursday, April 20, 2017 7:17:27 AM

Post# of 3970
RedHill Biopharma Announces Peer-Reviewed Publication of the Positive YELIVA® Phase I Study Results in Advanced Solid Tumors

http://finance.yahoo.com/news/redhill-biopharma-announces-peer-reviewed-110000315.html

Read at the end of article - 4 different P I/II trials on 4 different cancers under way - all externally funded
Plus one ODD

Yeliva is showing great potential and making good progress.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News